Do you want to read an article? Please log in or register.
CT-based Airway Surface Area to Volume Ratio for Phenotyping Airway Remodeling in Chronic Obstructive Pulmonary Disease.
COPD
RECOMMENDED
Related content
RECOMMENDED
COPDSleep Apnea
Prevalence and Predictors of Obstructive Sleep Apnea in Patients with Chronic Obstructive Pulmonary Disease Undergoing Inpatient Pulmonary Rehabilitation
COPD.
Schreiber A, Cemmi F, Ambrosino N, Ceriana P, Lastoria C, Carlucci A
doi: 10.1080/15412555.
COMMENTED
COPD
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS
Ann Am Thorac Soc.
Ghosh S, Anderson WH, Putcha N, Han MK, Curtis JL, Criner GJ, Dransfield MT, Barr RG, Krishnan JA, Lazarus SC, Cooper CB, Paine R 3rd, Peters SP, Hansel NN, Martinez FJ, Drummond MB, Current and former investigators of the SPIROMICS sites and reading centers
doi: 10.1513/AnnalsATS.201804-283OC.
COPDPneumonia
Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention
Eur J Cardiothorac Surg.
Andell P, Sjögren J, Batra G, Szummer K, Koul S
doi: 10.1093/ejcts/ezx219.
RECOMMENDED
COPD
Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Semin Respir Crit Care Med.
Gupta N, Haley R, Gupta A, Sethi S
doi: 10.1055/s-0040-1708837.
COPD
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
Lancet Respir Med.
Gedebjerg A, Szépligeti SK, Wackerhausen LH, Horváth-Puhó E, Dahl R, Hansen JG, Sørensen HT, Nørgaard M, Lange P, Thomsen RW2
doi: 10.1016/
RECOMMENDED
COPD
Small airway inflammation and extrafine inhaled corticosteroids plus long-acting beta2-agonists formulations in chronic obstructive pulmonary disease
Respir Med.
Pirina P, Foschino Barbaro MP, Paleari D, Spanevello A
doi: 10.1016/j.rmed.2018.08.013.
RECOMMENDED
COPD
Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts.
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Moll M, Sakornsakolpat P, Shrine N, Hobbs BD, DeMeo DL, John C, Guyatt AL, McGeachie MJ, Gharib SA, Obeidat M, Lahousse L, Wijnant SRA, Brusselle G, Meyers DA, Bleecker ER, Li X, Tal-Singer R, Manichaikul A, Rich SS, Won S, Kim WJ, Do AR, Washko GR, Barr RG, Psaty BM, Bartz TM, Hansel NN, Barnes K, Hokanson JE, Crapo JD, Lynch D, Bakke P, Gulsvik A, Hall IP, Wain L, International COPD Genetics Consortium., SpiroMeta Consortium., Weiss ST, Silverman EK, Dudbridge F, Tobin MD, Cho MH
doi: 10.1016/S2213-2600(20)30101-6.
Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease
Eur Respir J.
Lahousse L, Seys LJM, Joos GF, Franco OH, Stricker BH, Brusselle GG
doi: 10.1183/13993003.
COMMENTED
COPD
Antibiotics for exacerbations of chronic obstructive pulmonary disease
Cochrane Database Syst Rev.
Vollenweider DJ, Frei A, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA
doi: 10.1002/14651858.